LUMAXIS
Dead / Cancelled — Cancelled — Section 8 (as of 02 May 2008)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 75276164
- Registration number
- 2473855
- Mark type
- Word mark
- Filed
- 17 Apr 1997
- Published for opposition
- 06 Jan 1998
- Registered
- 31 Jul 2001
- Attorney of record
- DON M KERR
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations, for the treatment of cardiovascular diseases, central nervous system diseases, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases and for diagnostic imaging
Owner
- DUPONT PHARMACEUTICALS COMPANY, WILMINGTON, DE, US
- DUPONT PHARMACEUTICALS COMPANY, WILMINGTON, DE, US
- DUPONT PHARMACEUTICALS COMPANY, WILMINGTON, DE, US
- DUPONT PHARMACEUTICALS COMPANY, WILMINGTON, DE, US
- DuPont Merck Pharmaceutical Company, The, Wilmington, DE, US
- DuPont Merck Pharmaceutical Company, The, Wilmington, DE, US
- DuPont Merck Pharmaceutical Company, The, Wilmington, DE, US
- DuPont Merck Pharmaceutical Company, The, Wilmington, DE, US
Prosecution history
- 02 May 2008 — CANCELLED SEC. 8 (6-YR)
- 14 Feb 2007 — CASE FILE IN TICRS
- 24 Jul 2002 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 31 Jul 2001 — REGISTERED-PRINCIPAL REGISTER
- 21 Feb 2001 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 10 Feb 2001 — ASSIGNED TO EXAMINER
- 07 Feb 2001 — STATEMENT OF USE PROCESSING COMPLETE
- 12 Dec 2000 — USE AMENDMENT FILED
- 12 Dec 2000 — SOU EXTENSION 5 GRANTED
- 27 Sept 2000 — SOU EXTENSION 5 FILED
- 12 Apr 2000 — SOU EXTENSION 4 GRANTED
- 22 Feb 2000 — SOU EXTENSION 4 FILED
- 28 Sept 1999 — SOU EXTENSION 3 GRANTED
- 02 Sept 1999 — SOU EXTENSION 3 FILED
- 15 Apr 1999 — SOU EXTENSION 2 GRANTED